XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting principle for ASU 2022-02
Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting principle for ASU 2022-02
Accumulated Other Comprehensive Loss, Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2022     72,263,727          
Balance at beginning of period at Dec. 31, 2022 $ 3,197,400 $ 1,277 $ 72,264 $ 1,935,211 $ 1,311,258 $ 1,277 $ (46,507) $ (74,826)
Balance at beginning of period (in shares) at Dec. 31, 2022               2,894,677
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     131,930          
Issuance of restricted shares 0   $ 132 (132)        
Issuance of common shares pursuant to PSU agreements (in shares)     102,973          
Issuance of common shares pursuant to PSU agreements 0   $ 103 (103)        
Proceeds from exercise of stock options (in shares)     16,000          
Proceeds from exercise of stock options 476   $ 16 460        
Share-based compensation 4,429     4,429        
Purchase of treasury shares (in shares)               480,170
Purchase of treasury shares (17,048)             $ (17,048)
Net income 123,056       123,056      
Dividends on common shares (20,849)       (20,849)      
Other comprehensive income (loss) during the period (4,111)           (4,111)  
Balance at end of period (in shares) at Jun. 30, 2023     72,514,630          
Balance at end of period at Jun. 30, 2023 3,284,630   $ 72,515 1,939,865 1,414,742   (50,618) $ (91,874)
Balance at end of period (in shares) at Jun. 30, 2023               3,374,847
Balance at beginning of period (in shares) at Mar. 31, 2023     72,484,210          
Balance at beginning of period at Mar. 31, 2023 3,253,195   $ 72,484 1,937,664 1,362,512   (35,581) $ (83,884)
Balance at beginning of period (in shares) at Mar. 31, 2023               3,110,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     30,420          
Issuance of restricted shares 0   $ 31 (31)        
Share-based compensation 2,232     2,232        
Purchase of treasury shares (in shares)               264,500
Purchase of treasury shares (7,990)             $ (7,990)
Net income 62,635       62,635      
Dividends on common shares (10,405)       (10,405)      
Other comprehensive income (loss) during the period (15,037)           (15,037)  
Balance at end of period (in shares) at Jun. 30, 2023     72,514,630          
Balance at end of period at Jun. 30, 2023 $ 3,284,630   $ 72,515 1,939,865 1,414,742   (50,618) $ (91,874)
Balance at end of period (in shares) at Jun. 30, 2023               3,374,847
Balance at beginning of period (in shares) at Dec. 31, 2023 72,516,079   72,516,079          
Balance at beginning of period at Dec. 31, 2023 $ 3,426,747   $ 72,516 1,945,385 1,539,957   (35,939) $ (95,172)
Balance at beginning of period (in shares) at Dec. 31, 2023 3,462,738             3,462,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     125,832          
Issuance of restricted shares $ 0   $ 126 (126)        
Issuance of common shares pursuant to PSU agreements (in shares)     63,301          
Issuance of common shares pursuant to PSU agreements 0   $ 63 (63)        
Forfeitures of restricted shares (in shares)     (8,003)          
Forfeitures of restricted shares (181)   $ (8) (173)        
Share-based compensation 5,823     5,823        
Purchase of treasury shares (in shares)               167,898
Purchase of treasury shares (7,955)             $ (7,955)
Net income 165,097       165,097      
Dividends on common shares (20,836)       (20,836)      
Other comprehensive income (loss) during the period $ (2,081)           (2,081)  
Balance at end of period (in shares) at Jun. 30, 2024 72,697,209   72,697,209          
Balance at end of period at Jun. 30, 2024 $ 3,566,614   $ 72,697 1,950,846 1,684,218   (38,020) $ (103,127)
Balance at end of period (in shares) at Jun. 30, 2024 3,630,636             3,630,636
Balance at beginning of period (in shares) at Mar. 31, 2024     72,683,199          
Balance at beginning of period at Mar. 31, 2024 $ 3,484,738   $ 72,683 1,948,352 1,603,832   (39,959) $ (100,170)
Balance at beginning of period (in shares) at Mar. 31, 2024               3,567,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     22,013          
Issuance of restricted shares 0   $ 22 (22)        
Forfeitures of restricted shares (in shares)     (8,003)          
Forfeitures of restricted shares (181)   $ (8) (173)        
Share-based compensation 2,689     2,689        
Purchase of treasury shares (in shares)               62,700
Purchase of treasury shares (2,957)             $ (2,957)
Net income 90,785       90,785      
Dividends on common shares (10,399)       (10,399)      
Other comprehensive income (loss) during the period $ 1,939           1,939  
Balance at end of period (in shares) at Jun. 30, 2024 72,697,209   72,697,209          
Balance at end of period at Jun. 30, 2024 $ 3,566,614   $ 72,697 $ 1,950,846 $ 1,684,218   $ (38,020) $ (103,127)
Balance at end of period (in shares) at Jun. 30, 2024 3,630,636             3,630,636